LY4268989

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4268989, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 2]